Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

Liu WM, Fowler DW, Smith P, Dalgleish AG. · 2010

Read Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. by Liu WM, Fowler DW, Smith P, Dalgleish AG. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2813751.txt.

Description

Liu, Fowler, Smith, and Dalgleish tested in 2010 whether standard chemotherapy can make tumors easier for the immune system to attack. Chemo drugs were long assumed to clash with immune therapy because they also harm immune cells. The team treated tumor cells with three common drugs and watched a display protein called HLA class 1, which flags cells for killing.

The drugs raised HLA display on tumor cells, even where it started low, and killer T cells then destroyed more of them. Blocking HLA erased that gain. Liquid from drug-treated tumors also matured dendritic cells, the scouts that train T cells, and T-cell growth rose. The findings suggest some chemo restores a slice of immune surveillance.

Catalog record

CREATORLiu WM, Fowler DW, Smith P, Dalgleish AG.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2813751

Browse the full library · About the Tower of Babel